Journal article
Effect of angiotensin-converting enzyme inhibition on C-reactive protein levels: The Ramipril C-Reactive pRotein Randomized evaluation (4R) trial results
Abstract
BACKGROUND: Plasma levels of the inflammatory biomarker C-reactive protein (CRP) predict cardiovascular risk and may represent a target for treating and/or monitoring risk-reduction strategies. The effect of angiotensin-converting enzyme inhibitors on CRP levels has not been adequately studied.
METHODS: A total of 264 men and women, with CRP levels of 2 mg/L or greater and no history of cardiovascular disease, were enrolled in a 12-week …
Authors
Verma S; Lonn EM; Nanji A; Browne K; Ward R; Robertson A; Conradson H; Hildebrand K; Brant R; Anderson TJ
Journal
Canadian Journal of Cardiology, Vol. 25, No. 7, pp. e236–e240
Publisher
Elsevier
Publication Date
July 2009
DOI
10.1016/s0828-282x(09)70508-2
ISSN
0828-282X